Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer; (AFT-19)
Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer; (AFT-19)
Trial Category:
Genitourinary
Phase
III
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE